Evidence map›Paper›PMID 24212058›Full record

ArticleNeuropharmacology2014

Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdala.

Andrew R Rau, Olusegun J Ariwodola, Jeff L Weiner

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Central adenosine ABritish journal of pharmacology · 2018
    Article
  13. Review
  14. Review
  15. Purinergic Signalling: Therapeutic Developments.Frontiers in pharmacology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew R RauDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA; Neuroscience Graduate Program, Wake Forest University Graduate School of Arts and Sciences, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA. Electronic address: arau@wakehealth.edu.
Olusegun J AriwodolaDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA. Electronic address: jariwodo@wakehealth.edu.
Jeff L WeinerDepartment of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1083, USA. Electronic address: jweiner@wfubmc.edu.
Wake Forest University · US

Funding

Synaptic Correlates of Vulnerability and Resilience to Alcohol Use DisordersR37AA017531 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WEINER, JEFFREY L. · 2014 to 2023
$3.5M
Translational Studies on Early-life Stress and Vulnerability to Alcohol AddictionP01AA021099 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2012 to 2016
$2.8M
Synaptic Correlates of Vulnerability and Resilience to Alcohol Use DisorderR01AA017531 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jeffrey L. Weiner · 2009 to 2026
$2.1M
Synaptic and Behavioral Correlates of Adeonsinergic Signaling in the BLAF31AA022046 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAU, ANDREW RYAN · 2012 to 2014
$121k
Symposium on Neuroimaging in AlcoholismR13AA017053 · NIAAA · YALE UNIVERSITY · PI KRYSTAL, JOHN H · 2007 to 2007
$63k
NIAAA NIH HHS AA022046NIAAA NIH HHS AA17053NIAAA NIH HHS AA21099NIAAA NIH HHS F31 AA022046NIAAA NIH HHS P01 AA021099NIAAA NIH HHS R01 AA017531NIAAA NIH HHS R13 AA017053NIAAA NIH HHS R37 AA017531
6 · The paper itself

Abstract

The basolateral amygdala (BLA) plays an integral role in the etiology of anxiety disorders and alcoholism. Although much is known about the intrinsic circuitry that governs BLA excitability, our understanding of the neuromodulators that control BLA excitation is incomplete. In many brain regions, adenosine (ADO) regulates neuronal excitability, primarily via A₁ receptor inhibition of glutamate release, and basal adenosinergic tone is high enough to tonically inhibit neuronal excitation. Although ADO signaling modulates many anxiety- and alcohol-related behaviors, little is known about ADO regulation of BLA neurotransmission. To that end, we used patch clamp methods in rodent brain slices to characterize adenosinergic modulation of excitatory neurotransmission onto BLA pyramidal cells. ADO significantly inhibited EPSCs evoked by stimulation of either medial or external glutamatergic inputs into the BLA. This effect was mimicked by an A₁, but not by an A(₂a), agonist. Paired-pulse ratio and miniature EPSC experiments revealed that A₁ receptors reside at a presynaptic locus on BLA glutamatergic synapses. Moreover, bath application of an A1 receptor antagonist significantly enhanced EPSCs, providing evidence of tonic adenosinergic tone at BLA glutamatergic synapses. In addition, tonic ADO was regulated by adenosine kinase, but not adenosine deaminase. Finally, activation of A₁ receptors had no direct effects on the intrinsic excitability of BLA pyramidal cells. Collectively, these data suggest that tonic A₁ receptor signaling may play an important role in regulating BLA excitability and suggest a possible neurobiological substrate through which ADO may contribute to the pathophysiology of anxiety disorders and alcohol addiction.

Indexed as

AdenosineAdenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAmygdalaAnimalsExcitatory Postsynaptic PotentialsMaleNeuronsRatsRats, Sprague-DawleyReceptor, Adenosine A1SynapsesSynaptic TransmissionAdenosineAdenosine A1 Receptor AgonistsAdenosine A1 Receptor AntagonistsAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsReceptor, Adenosine A1AdenosineBasolateral amygdalaCyclopentyladenosineEPSCs

Identifiers

PMID24212058
PMCPMC3872110
OpenAlexW2097119941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.